Euclidean Capital as of Dec. 31, 2025
Portfolio Holdings for Euclidean Capital
Euclidean Capital holds 12 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vanguard Intl Equity Index F Allwrld Ex Us (VEU) | 59.5 | $220M | 3.0M | 73.56 | |
| Vanguard Index Fds Value Etf (VTV) | 26.9 | $99M | 520k | 190.99 | |
| Ishares Tr Msci India Etf (INDA) | 5.4 | $20M | 370k | 54.05 | |
| Foghorn Therapeutics (FHTX) | 2.3 | $8.5M | 1.6M | 5.40 | |
| Oric Pharmaceuticals (ORIC) | 2.2 | $8.1M | 989k | 8.18 | |
| Pmv Pharmaceuticals (PMVP) | 0.9 | $3.3M | 2.6M | 1.25 | |
| Spdr S&p 500 Etf Tr Tr Unit (SPY) | 0.8 | $2.8M | 4.1k | 681.92 | |
| Rapt Therapeutics Com New (RAPT) | 0.8 | $2.8M | 82k | 33.87 | |
| Alector (ALEC) | 0.6 | $2.0M | 1.3M | 1.56 | |
| Surrozen Com New (SRZN) | 0.5 | $2.0M | 88k | 22.60 | |
| Tenaya Therapeutics (TNYA) | 0.2 | $723k | 1.0M | 0.71 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $3.4k | 171k | 0.02 |
